Clarient, Sequenom: Early Volume Plays
Several stocks trading under $5 were poised to move on above-average volume during Monday's session.
09:17AM 11/30/09
Incyte, Sequenom: Early Volume Plays
Several stocks trading under $10 were poised to move on above-average volume during Monday's session.
09:23AM 11/25/09
Sequenom 3Q Loss Widens On Higher Costs, Sales Dip
Sequenom's 3rd-quarter loss widens on higher expenses, lower revenue
12:05PM 11/10/09
Midday Movers: Pump Up the Volume
Several small-cap stocks were moving on above-average volume during Thursday's session.
01:07PM 10/09/09
'Fast Money' Recap: Scavenging for Underperformers
An expert tells the panel that money managers see more upside in going after underperformers than well-established names.
08:19PM 10/07/09
Mannkind Falls on Talk of Partner, FDA Delay: BioBuzz
Company is delaying partnership talks for inhaled insulin product.
10:18AM 10/06/09
No Lupus Confab Invite for Immunomedics: BioBuzz
Epratuzumab data won't be presented at next week's rheumatology meeting.
07:42AM 10/06/09
Walgreen, Gannett, Warner Music Group Big Movers
Walgreen, Gannett, Warner Music Group, Sequenom, CIT Group are among big market movers Tuesday
05:11PM 09/29/09
Sequenom Tumbles After Execs Fired Amid Test Woes
Sequenom shares dive after CEO, other execs fired after mishandling of medical test results
01:32PM 09/29/09
A Sale May Be Sequenom's Only Option
Launching a successful prenatal genetic test for Down syndrome may be beyond Sequenom's reach.
08:02AM 09/29/09
Sequenom Study Found Unreliable
An investigation of Sequenom's study methods finds the firm's data was unreliable and misreported, leading to an executive purging.
12:38AM 09/29/09
NEW YORK (TheStreet) -- These bio-tech stocks have hit their 52 week highs - we put them thru our screen to see if they will they break out or break down?
01:38PM 09/23/09
'Mad Money Lightning Round': Go With Crown Holdings
Cramer loves the packaging space, especially Crown Holdings, which he calls a winner.
07:30PM 09/09/09



Connect with TheStreet